The ValidCare CBD liver safety study appears to be the final known piece of the puzzle when it comes to FDA releasing its CBD Enforcement Discretion Policy for CBD Products
It may also be the final pre-requisite for HR 841 — The CBD Legalization Bill — to move through the House
The results from the Validcare study are expected to be published in the near future
I’ve just reached out to Patrick, the CEO of ValidCare, to try to get the latest news on a timeline
Last time I communicated with him was in early Feb and they were “really close now” and “weeks away” from concluding the study
I know that Covid has pushed back the timeline a bit since the study began in August 2020, but the finish line can’t be very far away at this point
Sleek
News 
Market Data 
Discover 
